Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.

Chih-Chieh Hsu(Chang Gung Memorial Hospital), Chun‐Nan Yeh(Chang Gung University), Jeng‐Hwei Tseng(Chang Gung University), Tsung-Wen Chen(Chang Gung University), Jen‐Shi Chen(Linkou Chang Gung Memorial Hospital), Kun‐Chun Chiang(Chang Gung University), Chiao‐En Wu(Chang Gung University), Ta‐Sen Yeh(Chang Gung Memorial Hospital), Yi-Yin Jan(Chang Gung Memorial Hospital), Chun-Yi Tsai(Chang Gung Memorial Hospital), Yuyin Liu(Chang Gung University), Yen‐Yang Chen(Chang Gung University), Chi‐Tung Cheng(Chang Gung Memorial Hospital)
PubMed
September 1, 2014
Cited by 21

Related Papers

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1.1k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Intraductal papillary neoplasia of the liver associated with hepatolithiasis
|Hepatology|2001|282
Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct—an immunohistochemical study of 110 cases of hepatolithiasis
|Journal of Hepatology|2005|254